President and CEO Emil D Kakkis sold $4.1M of Ultragenyx Pharmaceutical Inc.

Sold$4,107,000

$136.90Price

30,000Shares

−1%Stake

What RARE did after the filing

Prices for RARE after this filing aren't in yet.

Traded Mon, Jan 4. Filed Tue, Jan 5, 6:45 PM ET, after the close. Not investment advice.